Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cytek Biosciences Q4 Sales $58.60M Beat $56.58M Estimate

Author: Benzinga Newsdesk | February 28, 2024 06:11pm
Cytek Biosciences (NASDAQ:CTKB) reported quarterly sales of $58.60 million which beat the analyst consensus estimate of $56.58 million by 3.57 percent. This is a 21.25 percent increase over sales of $48.34 million the same period last year.

Posted In: CTKB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist